Posts in category: News

Event Date: July 18, 2026

XenoFarma successfully organized a specialized scientific meeting on July 18, 2026, bringing together a distinguished group of radiotherapists to discuss important gastrointestinal considerations encountered during radiotherapy treatment.

The session focused on evidence-based approaches to optimizing gastrointestinal care before and during radiotherapy. Particular attention was given to the clinical role of PURGOTEC® in bowel preparation and rectal evacuation, especially in patients undergoing prostate radiotherapy, where appropriate bowel management contributes to treatment accuracy and patient comfort.

The meeting also highlighted the benefits of TRIO-ZYME® in the management of common gastrointestinal symptoms, including dyspepsia, bloating, indigestion, and occasional acidity. The discussion reviewed practical considerations for supporting digestive health and improving patient comfort throughout the course of treatment.

The session encouraged active scientific discussion and exchange of clinical experience among participants, providing an opportunity to review practical strategies that can be incorporated into routine radiotherapy practice.

XenoFarma remains committed to supporting continuous medical education and advancing multidisciplinary collaboration through scientific meetings that promote evidence-based patient care and improved clinical outcomes.

Event Date: June 29, 2026
Start Time: 9:00 AM
Venue: Emergency Hospital for Trauma and Burn
City: Erbil, Iraq

A specialized Round Table Discussion titled “Advanced Drug Delivery in Wound Management & Neuro-Regenerative Protocols” was successfully held on June 29, 2026, at the Emergency Hospital for Trauma and Burn in Erbil. The meeting brought together clinicians working in emergency, trauma, and burn care to discuss emerging innovations in the management of complex injuries.

The scientific session focused on the evolving role of Advanced Drug Delivery Systems (ADDS) in wound management, highlighting modern approaches designed to improve targeted drug delivery, support tissue repair, and optimize post-traumatic recovery. Participants also explored the growing field of neuro-regenerative protocols, reviewing current concepts and their potential contribution to improving functional recovery following traumatic injuries.

The interactive round table encouraged scientific dialogue and the exchange of clinical experience, allowing participants to discuss practical applications of these emerging technologies in emergency medicine and trauma care.

XenoFarma remains committed to supporting continuous medical education by facilitating high-quality scientific meetings that promote innovation, evidence-based practice, and multidisciplinary collaboration across Iraq.

On June 4, 2026, XenoFarma organized an exclusive scientific meeting at Geverke Restaurant in Duhok, bringing together a distinguished group of General Surgeons to discuss emerging innovations in wound management and post-operative care.

The scientific session, titled “Advanced and Novel Drug Delivery in the Management of Wounds,” focused on modern therapeutic approaches designed to enhance wound healing outcomes and support effective infection control. Particular attention was given to innovative drug delivery technologies that optimize local therapeutic action while promoting tissue repair and recovery.

During the meeting, participants explored a patented biocompatible approach to enhanced wound healing and antimicrobial protection, highlighting its potential role in supporting post-operative recovery, reducing infection risks, and improving overall wound management strategies. The discussion also reviewed key aspects of the wound healing process and the importance of integrating advanced technologies into contemporary surgical practice.

The event provided an interactive platform for scientific exchange, allowing surgeons to discuss clinical experiences, share practical insights, and evaluate emerging solutions that may contribute to improved patient outcomes.

Through such educational initiatives, XenoFarma continues to support continuous medical education and the advancement of evidence-based surgical care across Iraq.

Event Date: June 4, 2026
Start Time: 12:27 PM
Venue: Geverke Restaurant
City: Duhok, Iraq

A multidisciplinary scientific round table was successfully held on February 1, 2026, in Ranyah, bringing together physicians from multiple specialties, including General Practitioners, Gynecologists, and General Surgeons. The event provided a dynamic platform for scientific exchange and practical clinical discussion focused on updated, evidence-based approaches in daily medical practice.

The session highlighted the clinical value of Golaprop as a novel mucoadhesive approach for upper respiratory tract infections (URTIs). The discussion emphasized how enhanced mucosal adhesion and localized action contribute to effective symptom control and improved patient comfort, particularly in common upper respiratory conditions.

In addition, the round table addressed the role of Rinisona in the management of adenoidal hypertrophy, with emphasis on its benefits in reducing nasal obstruction, improving breathing quality, and enhancing overall quality of life. The discussion focused particularly on mild to moderate clinical cases, where conservative and targeted management plays a critical role.

The session was highly interactive, featuring active participation, case-based discussion, and extended Q&A, followed by individual scientific exchanges that allowed deeper clarification of clinical scenarios.

Through such focused educational initiatives, XenoFarma continues to support practical, evidence-driven medical education and multidisciplinary collaboration, reinforcing its commitment to advancing patient care across Iraq.

Event Date: February 1, 2026
Start Time: 12:00 PM
Venue: Chestamala Restaurant
City: Ranyah, Iraq

A scientific round table discussion titled “Evaluating the Role of ProGest in Preterm Birth” was successfully conducted in Mosul on January 27, 2026, organized by Laboratorio ELEA and attended by a group of practicing gynecologists.

The session focused on the clinical application of ProGest® (micronized progesterone) in modern gynecological and obstetric practice. Evidence-based guidance was provided regarding appropriate dosing, treatment duration, and patient selection, with emphasis on ensuring safe and effective use in daily clinical settings.

Key clinical indications discussed included threatened miscarriage, luteal phase support in IVF/ART cycles, and prevention of preterm birth in high-risk pregnancies. The discussion highlighted the role of progesterone therapy in optimizing maternal and fetal outcomes while aligning treatment decisions with current clinical evidence.

The round table format encouraged active participation, allowing attendees to engage in open scientific dialogue and exchange practical clinical experiences. Follow-up individual scientific discussions further supported clarification of specific cases and strengthened professional engagement.

Through such focused educational initiatives, XenoFarma and its partners continue to support evidence-driven obstetric care and continuous medical education for healthcare professionals across Iraq.

Event Date: January 27, 2026
Start Time: 8:30 PM
Venue: White Tower Hotel
City: Mosul, Iraq

A scientific round table discussion titled “Prediction and Prevention of Spontaneous Preterm Birth” was successfully conducted in Sulaymaniyah on January 29, 2026, organized by Laboratorio ELEA and attended by a group of gynecologists from the region.

The session focused on the clinical role of ProGest® (micronized progesterone) in obstetric and reproductive practice, providing evidence-based guidance on appropriate dosing, treatment duration, and patient selection. The discussion addressed key clinical indications, including threatened miscarriage, luteal phase support in IVF/ART cycles, and prevention of preterm birth in high-risk pregnancies.

Special emphasis was placed on optimizing maternal and fetal outcomes while ensuring safe and rational use of progesterone therapy in daily clinical practice. The round table format encouraged active participation, enabling attendees to engage in focused scientific dialogue and exchange real-world clinical experiences.

The event concluded with individual, scientific follow-up discussions, providing deeper clarification of clinical scenarios and reinforcing engagement with participating gynecologists.

Through such targeted educational activities, XenoFarma and its partners continue to support evidence-driven obstetric care, professional knowledge exchange, and improved clinical outcomes in maternal health.

Event Date: January 29, 2026
Start Time: 12:00 PM
Venue: Titanic Hotel
City: Sulaymaniyah, Iraq

An exclusive scientific gathering for plastic and reconstructive surgeons was held on January 22, 2026, at the Titanic Hotel in Sulaymaniyah, focusing on advanced strategies in tissue repair and post-operative care. The event was organized in collaboration with XenoFarma and Erbozeta, bringing together leading specialists from the region.

The scientific session, titled “A Patented Biocompatible Approach to Enhanced Wound Healing and Antimicrobial Protection,” explored emerging technologies designed to optimize post-surgical outcomes. As the field of plastic surgery continues to evolve, the demand for solutions that support rapid tissue regeneration, effective antimicrobial protection, and improved scar management has become increasingly critical.

The discussion highlighted the role of patented biocompatible technologies in promoting wound healing while maintaining a high level of safety against infection. Emphasis was placed on their application in post-operative recovery, complex wound management, and aesthetic surgical outcomes.

The interactive format encouraged professional dialogue and experience sharing, allowing surgeons to evaluate how innovative wound care solutions can be integrated into daily clinical practice.

Through such focused scientific initiatives, XenoFarma continues to reinforce its commitment to advancing surgical care, supporting continuous medical education, and introducing evidence-driven innovations that enhance patient recovery and clinical excellence.

Event Date: January 22, 2026
Start Time: 1:00 PM
Venue: Titanic Hotel
City: Sulaymaniyah, Iraq

A specialized clinical seminar focusing on supportive care in oncology was held on January 25, 2026, at the Awat Center for Radiation Oncology in Erbil, in collaboration with XenoFarma and Erbozeta. The event was designed specifically for radiation oncologists, with the aim of improving quality of life and long-term outcomes for cancer survivors.

The seminar featured a dual-topic scientific agenda addressing two clinically relevant post-radiation challenges:

Targeted Management of Radiation Proctitis with Dual-Phase Therapy
This session explored innovative therapeutic protocols for managing radiation-induced proctitis, emphasizing targeted, phase-based treatment strategies aimed at reducing tissue inflammation, promoting healing, and minimizing long-term complications.

Recent Guideline Updates on the Non-Antibiotic Management of Recurrent Cystitis
The second session reviewed contemporary guideline updates focusing on non-antibiotic approaches to recurrent cystitis, particularly in the context of post-radiation complications. Emphasis was placed on antibiotic stewardship, recurrence prevention, and supportive strategies aligned with modern clinical recommendations.

By integrating updated guidelines and targeted therapeutic approaches into daily practice, the seminar highlighted the evolving role of evidence-based supportive care in radiation oncology. The interactive format encouraged clinical discussion and knowledge exchange among specialists.

XenoFarma continues to support high-level scientific education and multidisciplinary collaboration, reinforcing its commitment to advancing oncology supportive care through innovative, guideline-driven solutions.

Event Date: January 25, 2026
Start Time: 12:00 PM
Venue: Awat Center for Radiation Oncology
City: Erbil, Iraq

A specialized scientific meeting titled “Antibiotic Stewardship: Recent Guideline Updates on the Non-Antibiotic Management of Recurrent Cystitis” was successfully held on January 21, 2026, at the Ramada Hotel in Sulaymaniyah, in collaboration with XenoFarma and Erbozeta.

The meeting brought together urologists from across the region to address one of the most critical challenges in modern urological practice: antibiotic stewardship in the era of rising antimicrobial resistance. The scientific discussion focused on recent international guideline updates that emphasize evidence-based, non-antibiotic strategies for the prevention and management of recurrent cystitis.

Key topics included the clinical rationale for reducing unnecessary antibiotic exposure, the impact of resistance on patient safety, and the role of supportive and preventive approaches that align with contemporary stewardship principles. The session highlighted the importance of integrating guideline-driven, non-antibiotic interventions into routine urological practice to reduce recurrence rates while preserving antimicrobial efficacy.

The meeting fostered an open and interactive scientific dialogue, enabling urologists to exchange clinical experiences and discuss practical implementation of stewardship strategies in daily practice.

Through such focused educational initiatives, XenoFarma continues to support responsible antibiotic use, continuous medical education, and the advancement of evidence-based urological care across Iraq.

Event Date: January 21, 2026
Start Time: 7:00 PM
Venue: Ramada Hotel – Sulaymaniyah
City: Sulaymaniyah, Iraq

A specialized scientific discussion for pediatric surgeons was held on January 5, 2026, at HuQQabaz, Empire World – Erbil, in collaboration with the Kurdistan Pediatric Surgeons Association. The event brought together experienced pediatric surgeons for an in-depth, evidence-based exchange addressing key challenges in contemporary pediatric surgical practice.

The session focused on two critical clinical areas:
(1) Evidence-based management of pediatric constipation, and
(2) Bio-compatible post-surgical wound care for optimal healing.

The scientific discussion examined clinical mechanisms, safety profiles, and practical therapeutic considerations, with special emphasis on PURGOTEC-C effervescent suppositories as a supportive solution in pediatric constipation, and CicaSilverMed as a biocompatible wound care dressing designed to promote optimal postoperative recovery.

An interactive format encouraged clinical case discussion and expert dialogue, allowing surgeons to exchange real-world experiences and evaluate treatment strategies aligned with evidence-based practice.

The event reflected XenoFarma’s ongoing commitment to high-quality scientific engagement, reinforcing its role as a trusted partner in advancing pediatric surgical care through innovative and clinically relevant solutions that support both patient outcomes and surgical standards.

Event Date: January 5, 2026
Start Time: 1:00 PM
Venue: HuQQabaz – Empire World
City: Erbil, Iraq